Peripheral Artery Disease (PAD)

This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia. 

According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be valued at $2,897.2 million in 2022 and is expected to exhibit a CAGR of 6.6 % during the forecast period (2022-2030).
News | Stents Drug Eluting
Global Drug Eluting Stents Market to Surpass US$ 4,844.6 Million by 2030, Says Coherent Market Insights

December 23, 2022 — According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be ...

Home December 23, 2022
Home
Certain adults with this artery-blocking condition may see more benefits with an open bypass compared to less-invasive procedures to improve circulation.
News | Peripheral Artery Disease (PAD)
Bypass Surgery Favorable for Initial Treatment of Chronic Limb-Threatening Ischemia

November 15, 2022 Performing open bypass surgery to restore circulation for people with a severe form of peripheral ...

Home November 15, 2022
Home
Edwin A. Takahashi, M.D., assistant professor of radiology in the division of interventional radiology at the Mayo Clinic College of Medicine in Rochester, Minnesota. Copyright Mayo Clinic College of Medicine
News | AHA
Telehealth is a Valuable Option in Cardiovascular Care, Though Challenges Remain

November 15, 2022 — Telehealth is a proven and valuable option for people with cardiovascular disease, however, there ...

Home November 15, 2022
Home
Grant Proceeds Will Support Pre-Clinical Studies
News | Stents Bioresorbable
Efemoral Medical Awarded Phase II SBIR Grant from NIH to Advance Treatment for Peripheral Artery Disease

October 11, 2022 —  Efemoral Medical, developer of advanced interventional bioresorbable therapies, announced that it ...

Home October 11, 2022
Home
The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon.
News | Drug-Eluting Balloons
First US Patient Enrolled in SELUTION SLR IDE Peripheral Study

August 23, 2022 — The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial ...

Home August 23, 2022
Home
A) Patients with prior COVID have higher rates of impaired MFR indicating cardiovascular disease B) Impaired MFR is associated with a higher rate of adverse events in patients with no prior COVID and those with prior COVID
News | Heart Failure
Hackensack University Medical Center Becomes Second Hospital in the World to Implant New Heart Pump to Treat Chronic Heart Failure

August 19, 2022 —  Hackensack Meridian Health, Hackensack University Medical Center cardiac surgeon Yuriy Dudiy, M.D. be ...

Home August 19, 2022
Home
a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part of Main Line Health, used experimental models to discover that a natural product found in plants including safflower holds promise for treating a pair of hereditary sudden cardiac death syndromes
News | Atherectomy Devices
Northeast Scientific Inc. wins 510(k) for Turbo-Elite Laser Atherectomy Catheter reprocessing

July 28, 2022 — Northeast Scientific Inc., pioneers in reprocessing single use peripheral vascular catheters, announced ...

Home July 28, 2022
Home
The BIO REACT study was designed to better understand when and where a stent is needed following drug-coated balloon for the treatment of femoropopliteal artery lesions in patients with peripheral artery disease (PAD)
News | Drug-Eluting Balloons
New Data at LINC 2022 Confirm Passeo-18 Lux Drug-Coated Balloon is a Safe and Effective Treatment in Challenging Patient Groups

July 12, 2022 — Biotronik announced the presentation of two studies on the performance of its drug-coated balloon ...

Home July 12, 2022
Home
 For below-the-knee arterial dissection repair following balloon angioplasty, innovative medical technology shows sustained treatment effect and positive impact on quality of life for patients with critical limb ischemia (CLI)
News | Peripheral Artery Disease (PAD)
Philips Announces Positive Three-year Clinical Research Results from its Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) Clinical Trial

June 13, 2022 — Royal Philips announced the latest results from the Tack Optimized Balloon Angioplasty (TOBA) II below ...

Home June 13, 2022
Home
COMPASS open label extension study results support the long-term use of XARELTO plus aspirin for vascular protection in patients with chronic CAD and/or PAD
News | Cardiovascular Clinical Studies
New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition with XARELTO Plus Aspirin in Patients with Coronary Artery Disease, Peripheral Artery Disease

May 31, 2022 — Findings from the XARELTO (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and ...

Home May 31, 2022
Home
Three years ago a study raised concerns that paclitaxel-coated devices may cause increased mortality in peripheral artery disease patients. However, numerous studies now show there is no risk of increased mortality. The most recent study is the SAFE-PAD study presented at SCAI22.
News | Peripheral Artery Disease (PAD)
New Longterm Data of Paclitaxel Devices Continues to Show No Increased Mortality Compared to Non-drug Coated Devices

May 20, 2022 — New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel ...

Home May 20, 2022
Home
First multi-center, randomized controlled study provides the largest long-term evidence for the treatment of heavily calcified femoropopliteal lesions
News | Peripheral Artery Disease (PAD)
Disrupt PAD III Trial Demonstrates Safety and Effectiveness of Intravascular Lithotripsy for Peripheral Artery Calcification

May 19, 2022 — One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug ...

Home May 19, 2022
Home
 Transit Scientific announced the FDA clearance of its XO Cross Support Catheter Platform to include coronary use.
News | Guidewires
FDA Clears Four New Coronary Micro Support Catheters

April 12, 2022 — Transit Scientific announced the FDA clearance of its XO Cross Support Catheter Platform to include ...

Home April 12, 2022
Home
With 60 years of experience, The Cardiovascular Care Group is nationally recognized for vascular and endovascular care. In addition to providing quality care to tens of thousands of patients over the years, The Cardiovascular Care Group has been committed to educating the community on vascular-related conditions through the sharing of knowledge and transparency.
News | Peripheral Artery Disease (PAD)
The Cardiovascular Care Group Raises Awareness of Peripheral Artery Disease


March 22, 2022 – With 60 years of experience, The Cardiovascular Care Group is nationally recognized for vascular ...

Home March 22, 2022
Home
Medtronic is recalling (correcting) the TurboHawk Plus Directional Atherectomy System due to design similarities shared with another device that was recently recalled for correction.
News | Atherectomy Devices
Class I Recall on TurboHawk Plus Directional Atherectomy System by Medtronic

March 9, 2022 — Medtronic is recalling (correcting) the TurboHawk Plus Directional Atherectomy System due to design ...

Home March 09, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now